MRF-Logo2019-Horizontal-RGB
ly2875358
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

ly2875358

› Forums › Ocular Melanoma Community › ly2875358

  • Post
    • February 27, 2013 at 4:32 pm
    margaretrogers57
    Participant

      Has anyone heard of Ly2875358 for metastic uveal melanoma?   It is a Lily drug affecting the c-mets.  It specifically mentions uveal in one arm..Margaret

      Has anyone heard of Ly2875358 for metastic uveal melanoma?   It is a Lily drug affecting the c-mets.  It specifically mentions uveal in one arm..Margaret

    Viewing 2 reply threads
    • Replies
        • March 1, 2013 at 2:45 pm
        ThatHomeschoolDad
        Participant

          Not sure about that one, but Lily just asked Sato for 15 ocular patients to do a Phase one on a C-MEK inhibitor:

          Check clinicaltrials.gov for # LY2801653.  I might jump on that this spring — still waiting to see what Ipi/sterotactic did.

          LY2875358 (C-MET), looks like it's at about the same developmental stage as the C-MEK trail, so that one may be in the pipeline at Jefferson as well.

           

          –Tom

          • March 1, 2013 at 2:45 pm
          ThatHomeschoolDad
          Participant

            Not sure about that one, but Lily just asked Sato for 15 ocular patients to do a Phase one on a C-MEK inhibitor:

            Check clinicaltrials.gov for # LY2801653.  I might jump on that this spring — still waiting to see what Ipi/sterotactic did.

            LY2875358 (C-MET), looks like it's at about the same developmental stage as the C-MEK trail, so that one may be in the pipeline at Jefferson as well.

             

            –Tom

            • March 1, 2013 at 2:45 pm
            ThatHomeschoolDad
            Participant

              Not sure about that one, but Lily just asked Sato for 15 ocular patients to do a Phase one on a C-MEK inhibitor:

              Check clinicaltrials.gov for # LY2801653.  I might jump on that this spring — still waiting to see what Ipi/sterotactic did.

              LY2875358 (C-MET), looks like it's at about the same developmental stage as the C-MEK trail, so that one may be in the pipeline at Jefferson as well.

               

              –Tom

          Viewing 2 reply threads

          Tagged: 

          • You must be logged in to reply to this topic.
          About the MRF Patient Forum

          The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

          The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.